← Back to headlines

Alector Stock Plummets as GSK Terminates Neuroscience Pact
Alector's stock dropped by 13% following the termination of its neuroscience partnership with GSK.
9 Jul, 04:23 — 9 Jul, 04:23
Sources
Showing 1 of 1 sources

Alector's stock dropped by 13% following the termination of its neuroscience partnership with GSK.